BR9915123A - Composição de uma substância farmaceuticamente ativa e dispensador - Google Patents
Composição de uma substância farmaceuticamente ativa e dispensadorInfo
- Publication number
- BR9915123A BR9915123A BR9915123-5A BR9915123A BR9915123A BR 9915123 A BR9915123 A BR 9915123A BR 9915123 A BR9915123 A BR 9915123A BR 9915123 A BR9915123 A BR 9915123A
- Authority
- BR
- Brazil
- Prior art keywords
- dispenser
- composition
- pharmaceutically active
- active substance
- substance
- Prior art date
Links
- 239000013543 active substance Substances 0.000 title abstract 2
- 239000000126 substance Substances 0.000 abstract 2
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0258—Escherichia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5258—Virus-like particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55544—Bacterial toxins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16211—Influenzavirus B, i.e. influenza B virus
- C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18711—Rubulavirus, e.g. mumps virus, parainfluenza 2,4
- C12N2760/18734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pulmonology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Otolaryngology (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Patente de Invenção:<B>"COMPOSIçãO DE UMA SUBSTâNCIA FARMACEUTICAMENTE ATIVA E DISPENSADOR"<D>. A presente invenção refere-se a uma substância farmaceuticamente aperfeiçoada bem como a um dispositivo dispensador aperfeiçoado desenvolvido para aplicação nasal eficaz de uma substância.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19851282A DE19851282A1 (de) | 1998-11-06 | 1998-11-06 | Zusammensetzung einer pharmazeutisch wirksamen Substanz, appliziert in einem spezifischen Delivery-System zur Prävention und Behandlung von Infektions-Krankheiten |
PCT/EP1999/008557 WO2000027430A2 (de) | 1998-11-06 | 1999-11-08 | Zusammensetzung bestehend aus influenzavirusoberflächenprotein, und abgabeeinrichtung |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9915123A true BR9915123A (pt) | 2001-07-31 |
Family
ID=7886959
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9915123-5A BR9915123A (pt) | 1998-11-06 | 1999-11-08 | Composição de uma substância farmaceuticamente ativa e dispensador |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP1126875B1 (pt) |
JP (1) | JP2002529427A (pt) |
KR (1) | KR20010080955A (pt) |
CN (1) | CN1331604A (pt) |
AT (1) | ATE353224T1 (pt) |
AU (1) | AU776669B2 (pt) |
BR (1) | BR9915123A (pt) |
CA (1) | CA2348474C (pt) |
CZ (1) | CZ20011567A3 (pt) |
DE (2) | DE19851282A1 (pt) |
ES (1) | ES2279650T3 (pt) |
HR (1) | HRP20010300A2 (pt) |
HU (1) | HUP0202931A2 (pt) |
PL (1) | PL348202A1 (pt) |
SK (1) | SK6092001A3 (pt) |
WO (1) | WO2000027430A2 (pt) |
ZA (1) | ZA200103607B (pt) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7226786B2 (en) | 1999-05-18 | 2007-06-05 | Dnavec Research Inc. | Envelope gene-deficient Paramyxovirus vector |
DE10125731A1 (de) * | 2001-05-17 | 2003-03-06 | A I D Autoimmun Diagnostika Gm | Darreichungsform von immunologischen Wirkstoffen |
EP1504766A4 (en) * | 2002-04-30 | 2006-11-02 | Dnavec Research Inc | MEDICAMENT OR GENE SUPPORT COMPOSITION WITH HEMAGGLUTININ ACTIVITY |
CN100425288C (zh) * | 2005-01-28 | 2008-10-15 | 北京金迪克生物技术研究所 | 鼻腔喷雾型流感病毒灭活疫苗及其制备方法 |
JP2008540586A (ja) | 2005-05-18 | 2008-11-20 | フォルシュングスフェアブント ベルリン エー ファウ | Akap−pka相互作用の非ペプチド阻害剤 |
ES2561060T3 (es) | 2005-10-28 | 2016-02-24 | Id Pharma Co., Ltd. | Transferencia génica en citoblastos epiteliales de las vías respiratorias mediante el uso de vectores de lentivíricos pseudotipados con una proteína espina de virus de ARN |
JPWO2007132790A1 (ja) * | 2006-05-12 | 2009-09-24 | 国立大学法人 北海道大学 | 細菌菌体成分を含む脂質膜を有するリポソーム |
NZ580603A (en) * | 2007-06-14 | 2013-02-22 | Crucell Switzerland Ag | Intradermal influenza vaccine |
JP2014140588A (ja) * | 2013-01-25 | 2014-08-07 | Shinko Chemical Co Ltd | 噴霧容器 |
CU24686B1 (es) * | 2018-06-05 | 2023-11-07 | Ct Ingenieria Genetica Biotecnologia | Composición de vacuna contra la hepatitis b, proceso de obtención de dicha composición y sistema de rinovacunación para prevenir y tratar la hepatitis b |
FR3119772A1 (fr) | 2021-02-15 | 2022-08-19 | Aptar France Sas | Tête de distribution pour dispositif de distribution nasale d’un produit fluide ou pulvérulent |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2434875A (en) * | 1945-08-11 | 1948-01-20 | Turnbull | Jetting device |
FR1257220A (fr) * | 1960-02-19 | 1961-03-31 | Dispositif nasal électro-thermique d'inhalation | |
DE8422872U1 (de) * | 1984-08-01 | 1984-10-25 | Anasco GmbH, 6200 Wiesbaden | Spender zur intranasalen applikation von fluessigkeiten in form von sprays oder tropfen |
JP2849632B2 (ja) * | 1988-04-08 | 1999-01-20 | 社団法人北里研究所 | ワクチン製剤 |
JP2922935B2 (ja) * | 1989-08-11 | 1999-07-26 | 東興薬品工業株式会社 | 粘稠液用鼻孔内噴霧容器の使捨てアダプタ |
IT1253009B (it) * | 1991-12-31 | 1995-07-10 | Sclavo Ricerca S R L | Mutanti immunogenici detossificati della tossina colerica e della tossina lt, loro preparazione ed uso per la preparazione di vaccini |
FR2739294B1 (fr) * | 1995-09-29 | 1998-01-16 | Lhd Lab Hygiene Dietetique | Embout nasal de securite |
US5797390A (en) * | 1996-03-06 | 1998-08-25 | Mcsoley; Thomas E. | Nasal inhaler having a directed spray pattern |
FR2764807B1 (fr) * | 1997-06-18 | 1999-08-20 | Valois Sa | Dispositif de distribution nasale d'un produit fluide ou pulverulent |
-
1998
- 1998-11-06 DE DE19851282A patent/DE19851282A1/de not_active Withdrawn
-
1999
- 1999-11-08 KR KR1020017005746A patent/KR20010080955A/ko not_active Application Discontinuation
- 1999-11-08 CN CN99814882A patent/CN1331604A/zh active Pending
- 1999-11-08 PL PL99348202A patent/PL348202A1/xx not_active Application Discontinuation
- 1999-11-08 SK SK609-2001A patent/SK6092001A3/sk unknown
- 1999-11-08 BR BR9915123-5A patent/BR9915123A/pt not_active IP Right Cessation
- 1999-11-08 HU HU0202931A patent/HUP0202931A2/hu unknown
- 1999-11-08 WO PCT/EP1999/008557 patent/WO2000027430A2/de not_active Application Discontinuation
- 1999-11-08 AU AU11612/00A patent/AU776669B2/en not_active Withdrawn - After Issue
- 1999-11-08 AT AT99971718T patent/ATE353224T1/de not_active IP Right Cessation
- 1999-11-08 EP EP99971718A patent/EP1126875B1/de not_active Revoked
- 1999-11-08 JP JP2000580659A patent/JP2002529427A/ja not_active Withdrawn
- 1999-11-08 CZ CZ20011567A patent/CZ20011567A3/cs unknown
- 1999-11-08 CA CA002348474A patent/CA2348474C/en not_active Expired - Fee Related
- 1999-11-08 DE DE59914183T patent/DE59914183D1/de not_active Revoked
- 1999-11-08 ES ES99971718T patent/ES2279650T3/es not_active Expired - Lifetime
-
2001
- 2001-04-26 HR HR20010300A patent/HRP20010300A2/hr not_active Application Discontinuation
- 2001-05-04 ZA ZA200103607A patent/ZA200103607B/en unknown
Also Published As
Publication number | Publication date |
---|---|
KR20010080955A (ko) | 2001-08-25 |
HUP0202931A2 (hu) | 2002-12-28 |
EP1126875B1 (de) | 2007-02-07 |
ATE353224T1 (de) | 2007-02-15 |
AU1161200A (en) | 2000-05-29 |
CA2348474C (en) | 2008-01-08 |
WO2000027430A2 (de) | 2000-05-18 |
PL348202A1 (en) | 2002-05-06 |
ES2279650T3 (es) | 2007-08-16 |
EP1126875A2 (de) | 2001-08-29 |
WO2000027430A3 (de) | 2000-11-23 |
CN1331604A (zh) | 2002-01-16 |
DE59914183D1 (de) | 2007-03-22 |
CZ20011567A3 (cs) | 2001-08-15 |
DE19851282A1 (de) | 2000-05-11 |
JP2002529427A (ja) | 2002-09-10 |
HRP20010300A2 (en) | 2002-06-30 |
CA2348474A1 (en) | 2000-05-18 |
AU776669B2 (en) | 2004-09-16 |
ZA200103607B (en) | 2003-09-30 |
SK6092001A3 (en) | 2001-12-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9803300A (pt) | Formulação farmacêutica. | |
BR9909138A (pt) | Combinação para o tratamento de dependência de álcool e drogas contendo um antagonista de opióide e um modulador de complexo receptor de nmda | |
BR9909565A (pt) | Derivados bicìclicos do ácido hidroxâmico | |
BR0113961A (pt) | Método de analgesia | |
BR9906758A (pt) | Método e composição para transferir zinco para a membrana nasal | |
AR018109A1 (es) | FORMULACIoN GALÉNICA ADMINISTRABLE POR VíA ORAL QUE PERMITE UNA ABSORCIoN MEJORADA DE PRINCIPIOS ACTIVOS, USO DE UN AGENTE MAJORADOR DE ABSORCIoN PARA PREPARAR UNA FORMA DE DOSIFICACIoN ADMINISTRABLE POR VíA ORAL Y PROCEDIMIENTO PARA PREPARAR DICHA FORMULACIoN GALÉNICA | |
ATE303131T1 (de) | Zusammensetzungen zur nasalen verabreichung | |
HUP0202311A2 (hu) | Aeroszollá alakított fertőzésgátló, gyulladásgátló és vértolulást gátló szerek az orrmelléküreg-gyulladás kezelésében | |
BR0107869A (pt) | Composições farmacêuticas eletrogiradas | |
AU2002225772A1 (en) | Therapeutic agents and methods of use thereof for treating an amyloidogenic disease | |
SG152257A1 (en) | Topical preparation containing ambroxol | |
BR0115965A (pt) | Composições farmacêuticas para a liberação oral de agentes farmacologicamente ativos | |
BRPI0400214A (pt) | Composições e aplicações farmacêuticas para a obtenção confiável de nìveis aceitáveis de testosterona no soro | |
FI962735A0 (fi) | 2-hydroksi-5-fenylatsobensoehapon johdannaisten käyttö paksusuolen syövän kemialliseen ehkäisyyn ja kemoterapeuttisena aineena | |
BR9916575A (pt) | Composição farmacêutica de liberação controlada com mesilato de tilidina como substância-ativa | |
BR9915123A (pt) | Composição de uma substância farmaceuticamente ativa e dispensador | |
ITMI981774A0 (it) | Composizioni farmaceutiche ad attivita' analgesica | |
BR0012696A (pt) | Composição oftálmica | |
BR9809022A (pt) | Composições antiinflamatórias nasais tópicas | |
BR9812553A (pt) | Formulação medicamentosa com liberação de substância ativa controlada | |
MA27539A1 (fr) | Nouvelle combinaison synergique contenant du roflumilast et du formoterol | |
BR9811458A (pt) | "sistema solvente para penetração melhorada de compostos farmacêuticos" | |
FI970331A0 (fi) | Lääkkeen antokoostumus virustenvastaisten aineiden nenään toteutettavaa antoa varten | |
WO2002062322A3 (en) | Glycine betaine and its use as anti-hemorrhagic agent | |
BR9916807A (pt) | Antagonistas de 5ht1 para terapia antidepressiva |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 5A, 6A E 7A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1913 DE 04/09/2007. |